185 related articles for article (PubMed ID: 24986561)
21. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.
Miller S; Rogers HA; Lyon P; Rand V; Adamowicz-Brice M; Clifford SC; Hayden JT; Dyer S; Pfister S; Korshunov A; Brundler MA; Lowe J; Coyle B; Grundy RG
Neuro Oncol; 2011 Aug; 13(8):866-79. PubMed ID: 21798848
[TBL] [Abstract][Full Text] [Related]
23. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
24. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
Chang Q; Ng HK
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):24-8. PubMed ID: 17374234
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
Kraus JA; Felsberg J; Tonn JC; Reifenberger G; Pietsch T
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):325-33. PubMed ID: 12175345
[TBL] [Abstract][Full Text] [Related]
26. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
Miyanaga T; Hirato J; Nakazato Y
Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
[TBL] [Abstract][Full Text] [Related]
28. RASSF1A promoter is highly methylated in primitive neuroectodermal tumors of the central nervous system.
Inda MM; Castresana JS
Neuropathology; 2007 Aug; 27(4):341-6. PubMed ID: 17899687
[TBL] [Abstract][Full Text] [Related]
29. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E; Myklebust TÅ; Cappelen J; Due-Tønnessen BJ; Due-Tønnessen P; Kepka A; Johannesen TB; Krossnes B; Lundar T; Maric S; Miletic H; Moholdt V; Myrmel KS; Nordberg T; Rydland J; Stokland T; Solem K; Solheim O; Torsvik I; Wikran GC; Zeller B; Wesenberg F; Bechensteen AG; Brandal P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27910. PubMed ID: 31264356
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.
Korshunov A; Okonechnikov K; Schmitt-Hoffner F; Ryzhova M; Sahm F; Stichel D; Schrimpf D; Reuss DE; Sievers P; Suwala AK; Kumirova E; Zheludkova O; Golanov A; Jones DTW; Pfister SM; Kool M; von Deimling A
Acta Neuropathol Commun; 2021 Feb; 9(1):20. PubMed ID: 33536079
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.
Bauman G; Fisher B; Cairney E; Ranger A; Dar AR; Ross J; Stitt L; MacDonald D
J Neurooncol; 2004 Jul; 68(3):285-94. PubMed ID: 15332333
[TBL] [Abstract][Full Text] [Related]
32. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
33. Genomic deletions in cell lines derived from primitive neuroectodermal tumors of the central nervous system.
Dallas PB; Terry PA; Kees UR
Cancer Genet Cytogenet; 2005 Jun; 159(2):105-13. PubMed ID: 15899381
[TBL] [Abstract][Full Text] [Related]
34. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
Frühwald MC; O'Dorisio MS; Dai Z; Tanner SM; Balster DA; Gao X; Wright FA; Plass C
Oncogene; 2001 Aug; 20(36):5033-42. PubMed ID: 11526488
[TBL] [Abstract][Full Text] [Related]
35. EGFR amplification is a real independent prognostic impact factor between young adults and adults over 45yo with wild-type glioblastoma?
Armocida D; Pesce A; Frati A; Santoro A; Salvati M
J Neurooncol; 2020 Jan; 146(2):275-284. PubMed ID: 31889239
[TBL] [Abstract][Full Text] [Related]
36. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
[TBL] [Abstract][Full Text] [Related]
37. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.
Talasila KM; Soentgerath A; Euskirchen P; Rosland GV; Wang J; Huszthy PC; Prestegarden L; Skaftnesmo KO; Sakariassen PØ; Eskilsson E; Stieber D; Keunen O; Brekka N; Moen I; Nigro JM; Vintermyr OK; Lund-Johansen M; Niclou S; Mørk SJ; Enger PO; Bjerkvig R; Miletic H
Acta Neuropathol; 2013 May; 125(5):683-98. PubMed ID: 23429996
[TBL] [Abstract][Full Text] [Related]
38. Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Keck MK; Sill M; Wittmann A; Joshi P; Stichel D; Beck P; Okonechnikow K; Sievers P; Wefers AK; Roncaroli F; Avula S; McCabe MG; Hayden JT; Wesseling P; Øra I; Nistér M; Kranendonk MEG; Tops BBJ; Zapotocky M; Zamecnik J; Vasiljevic A; Fenouil T; Meyronet D; von Hoff K; Schüller U; Loiseau H; Figarella-Branger D; Kramm CM; Sturm D; Scheie D; Rauramaa T; Pesola J; Gojo J; Haberler C; Brandner S; Jacques T; Sexton Oates A; Saffery R; Koscielniak E; Baker SJ; Yip S; Snuderl M; Ud Din N; Samuel D; Schramm K; Blattner-Johnson M; Selt F; Ecker J; Milde T; von Deimling A; Korshunov A; Perry A; Pfister SM; Sahm F; Solomon DA; Jones DTW
Acta Neuropathol; 2023 Jan; 145(1):49-69. PubMed ID: 36437415
[TBL] [Abstract][Full Text] [Related]
39. Relapse patterns in pediatric embryonal central nervous system tumors.
Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
[TBL] [Abstract][Full Text] [Related]
40. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]